What You Should Know:
– Arine, a San Francisco-based AI-driven platform that optimizes medication management, reduces costs and improves outcomes for health plans and providers today announced that it closed $11 million in an oversubscribed Series A round co-led by 111° West Capital Partners and Katalyst Ventures, with strategic investments from Magellan Health Inc. and SCAN Group.
– Medication mismanagement unnecessarily costs healthcare $1 in every $6 spent. Arine optimizes medication therapy and treatment plans – saving 1 in every 6 healthcare dollars spent. Arine’s approach meets patients where they are, creates a whole picture of each patient based on clinical, social, and behavioral data, and enables clinicians to provide personalized care. The platform’s thousands of algorithms intake and analyze multi-source data to recommend just-in-time clinical interventions for each individual patient at their point of need. These timely interventions reduce the total cost of care and drive a significant ROI for healthcare organizations.
– Arine plans to use the latest round of funding to rapidly scale its team and its technology platform from the 5.5M lives actively managed today.
